ICOTYDE\u2122 (icotrokinra) is the first and only targeted oral peptide indicated for the treatment of moderate-to-severe plaque psoriasis (PsO) in adults and adolescents aged 12 years and over, weighing at least 40kg, who are suitable for systemic therapy or phototherapy.<\/p>\n
Plaque psoriasis is a chronic, immune\u2011mediated condition characterised by excessive skin cell production, leading to inflamed, scaly plaques that can be itchy or painful.<\/p>\n
Icotyde (icotrokinra) Tablets<\/strong><\/p>\n Icotyde (icotrokinra) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n Note:<\/strong><\/em> ICOTYDE\u2122 (icotrokinra) was approved by the US FDA in March 2026 for the treatment of moderate-to-severe PsO. <\/strong>Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.<\/p>\n Therapy Class: Interleukin-23 (IL-23) receptor antagonistIs Icotyde (icotrokinra) available in India?<\/h4>\n
How to get Icotyde Tablets delivered in India?<\/h4>\n
Who can help source Icotyde Tablets in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"
\nCurrent Indication: Moderate-to-severe plaque psoriasis
\nMarket Sector: Dermatology<\/p>\n\n\n
\n Brand Name:<\/strong><\/td>\n Icotyde<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n icotrokinra Tablets<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Tablets: 200 mg<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Johnson & Johnson<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n